pI: 4.7168 |
Length (AA): 146 |
MW (Da): 16055 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
42 | 145 | 2dnw (A) | 2 | 97 | 28.00 | 0.0000000073 | 0.99 | 1.04693 | -0.49 |
48 | 107 | 2l4b (A) | 2 | 63 | 35.00 | 0.022 | 0.63 | 0.802659 | -0.2 |
51 | 138 | 1x3o (A) | 1 | 80 | 25.00 | 0.015 | 1 | 1.01444 | -1.73 |
52 | 136 | 3gzm (A) | 2 | 78 | 23.00 | 0.000028 | 0.93 | 0.902792 | -1.11 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127028)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G44620 | acyl carrier protein 1 |
Arabidopsis thaliana | AT1G65290 | acyl carrier protein 2 |
Brugia malayi | Bm1_19045 | acyl carrier protein, mitochondrial precursor, putative |
Candida albicans | CaO19.2439 | potential second version of mitochondrial acyl carrier protein more similar to N. crassa complex I 12 kD subunit |
Candida albicans | CaO19.9975 | potential second version of mitochondrial acyl carrier protein more similar to N. crassa complex I 12 kD subunit |
Candida albicans | CaO19.819 | similar to S. cerevisiae ACP1 (YKL192C) mitochondrial acyl carrier protein |
Candida albicans | CaO19.8439 | similar to S. cerevisiae ACP1 (YKL192C) mitochondrial acyl carrier protein |
Caenorhabditis elegans | CELE_Y56A3A.19 | Protein Y56A3A.19 |
Chlamydia trachomatis | CT_236 | acyl carrier protein |
Dictyostelium discoideum | DDB_G0291866 | NADH dehydrogenase ubiquinone 1, alpha/beta subcomplex |
Drosophila melanogaster | Dmel_CG9160 | mitochondrial acyl carrier protein 1 |
Escherichia coli | b1094 | acyl carrier protein (ACP) |
Echinococcus granulosus | EgrG_000581700 | acyl carrier protein mitochondrial |
Echinococcus granulosus | EgrG_002014600 | PP-binding domain containing protein |
Echinococcus granulosus | EgrG_002014700 | PP-binding domain containing protein |
Echinococcus multilocularis | EmuJ_000581700 | Acyl carrier protein, mitochondrial |
Homo sapiens | ENSG00000004779 | NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa |
Leishmania braziliensis | LbrM.27.0300 | acyl carrier protein, putative |
Leishmania donovani | LdBPK_270300.1 | Acyl carrier protein, mitochondrial, putative |
Leishmania infantum | LinJ.27.0300 | acyl carrier protein, putative |
Leishmania major | LmjF.27.0290 | acyl carrier protein, putative |
Leishmania mexicana | LmxM.27.0290 | acyl carrier protein, putative |
Loa Loa (eye worm) | LOAG_06305 | acyl carrier protein |
Mycobacterium leprae | ML1654 | MEROMYCOLATE EXTENSION ACYL CARRIER PROTEIN ACPM |
Mus musculus | 70316 | NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1 |
Mus musculus | 102634451 | predicted gene, 17257 |
Mycobacterium tuberculosis | Rv2244 | Meromycolate extension acyl carrier protein AcpM |
Mycobacterium ulcerans | MUL_1305 | acyl carrier protein |
Neospora caninum | NCLIV_023990 | Acyl carrier protein, related |
Oryza sativa | 4338621 | Os05g0377000 |
Oryza sativa | 4332854 | Os03g0352800 |
Oryza sativa | 4342743 | Os07g0222800 |
Plasmodium berghei | PBANKA_0305600 | acyl carrier protein, putative |
Plasmodium falciparum | PF3D7_0208500 | acyl carrier protein |
Plasmodium knowlesi | PKNH_0412600 | acyl carrier protein, putative |
Plasmodium vivax | PVX_003880 | acyl carrier protein, putative |
Plasmodium yoelii | PY04779 | acyl carrier protein, putative |
Saccharomyces cerevisiae | YKL192C | Acp1p |
Schistosoma japonicum | Sjp_0206140 | Acyl carrier protein, mitochondrial precursor, putative |
Schistosoma mansoni | Smp_015860 | acyl carrier protein |
Schmidtea mediterranea | mk4.000417.00 | Acyl carrier protein, mitochondrial |
Schmidtea mediterranea | mk4.000686.07 | Acyl carrier protein, mitochondrial |
Trypanosoma brucei gambiense | Tbg972.3.490 | acyl carrier protein, mitochondrial precursor, putative |
Trypanosoma brucei | Tb927.3.860 | Acyl carrier protein, mitochondrial |
Trypanosoma cruzi | TcCLB.511867.140 | Acyl carrier protein, mitochondrial, putative |
Toxoplasma gondii | TGME49_264080 | acyl carrier protein ACP |
Treponema pallidum | TP0808 | acyl carrier protein |
Theileria parva | TP02_0962 | acyl carrier protein, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0738 | acyl carrier protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.3.860 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.860 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.860 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.3.860 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b1094 | Escherichia coli | essential | goodall |
CELE_Y56A3A.19 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_Y56A3A.19 | Caenorhabditis elegans | slow growth | wormbase |
YKL192C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_0305600 | Plasmodium berghei | Essential | plasmo |
TGME49_264080 | Toxoplasma gondii | Essentiality uncertain | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Trypanosoma brucei | Acyl carrier protein, mitochondrial | Compounds | References |
Homo sapiens | NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa | Compounds | References |